Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model

Respiratory syncytial virus (RSV) is the cause of significant morbidity and mortality among infants, and despite decades of research there remains no licensed vaccine. SeVRSV is a Sendai virus (SeV)-based live intranasal vaccine that expresses the full length RSV fusion (F) gene. SeV is the murine c...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Jones, Bart G., Sealy, Robert E., Surman, Sherri L., Portner, Allen, Russell, Charles J., Slobod, Karen S., Dormitzer, Philip. R., DeVincenzo, John, Hurwitz, Julia L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4049121/
https://ncbi.nlm.nih.gov/pubmed/24721531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2014.03.088
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi